전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved60 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleJiangsu Topcel-KH Pharmaceutica…Phase 2

CD19 CAR T Arm (CD19 CAR T Arm)

Scleroderma, Systemic · CD19

#CD19#CGT#Phase2#Popular#cell-gene-therapy+5
Trials 56Status Recruiting
AntibodyLimited DatastaleNYU Langone HealthPhase 2

belimumab (belimumab)

Rheumatic Disease · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#Antibody#Phase2#Popular#monoclonal-antibody+3
Trials 51Status Recruiting
AntibodyLimited DatastaleSanofiPhase 3

Isatuximab SAR650984 (Isatuximab SAR650984)

Immune System Disorder · Plasma Cell Myeloma

#PlasmaCellMyeloma#Antibody#Phase3#monoclonal-antibody#ImmuneSystemDisorder+2
Trials 39Status Active
CGTLimited DatastaleBeijing BiotechPhase 1

B7-H3-CAR T Cells (B7-H3-CAR T Cells)

Central Nervous System Neoplasms; Atypical Teratoid/Rhabdoid Tumor · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 35Status Recruiting
CGTLimited DatastaleRui Therapeutics Co., LtdPhase 1

KN5501 (anti-CD19 CAR NK cells, anti-CD19 CAR NK cells (KN5501))

Systemic Lupus Erythematosus (SLE) · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 33Status Recruiting
CGTLimited DatastaleEssen BiotechPhase 2

CD19/BCMA CAR T-cells (CD19/BCMA CAR T-cells)

Systemic Lupus Erythematosus; Lupus Nephritis · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 32Status Recruiting
CGTLimited DatastaleRui Therapeutics Co., LtdPhase 1

anti-CD19 CAR-NK cells (anti-CD19 CAR-NK cells)

Refractory/Recurrent Central Nervous System Lymphoma · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 32Status Active
CGTLimited DatastaleVinmec Research Institute of St…Phase 1

Autologous CD19-Targeted CAR-T Cells (Autologous CD19-Targeted CAR-T Cells)

Refractory Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 31Status Recruiting
CGTLimited DatastaleChildren's Hospital of Philadel…Phase 2

CART19 (CART19)

SLE; Systemic Lupus Erythematosus (SLE) · SLE

#SLE#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 30Status Recruiting
CGTLimited DatastalePersonGen BioTherapeutics (Suzh…Preclinical

T cell injection targeting CD19 chimeric antigen receptor (T cell injection targeting CD19 chimeric antigen receptor)

Systemic Lupus Erythematosus; Idiopathic Inflammatory Myopathies · CD19

#CD19#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 30Status Active
CGTLimited DatastaleTaizhou HoudeAoke Biomedical Co…Phase 1

OH2 oncolytic virus (OH2 oncolytic virus)

Digestive System Neoplasms · Digestive System Neoplasms

#DigestiveSystemNeoplasms#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 14Status Active
CGTAAVLimited DatastaleBrain Neurotherapy Bio, Inc.Phase 1

AAV2-GDNF gene therapy (AAV2-GDNF gene therapy)

Multiple System Atrophy · Multiple System Atrophy

#MultipleSystemAtrophy#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 6Status Recruiting
CGTLimited DatastaleCity of Hope Medical CenterPhase 1

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes)

Central Nervous System Lymphoma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 6Status Recruiting
CGTLimited DatastaleiCell Gene TherapeuticsPhase 1

BCMA-CD19 cCAR T cells (BCMA-CD19 cCAR T cells)

Relapsed/Refractory, Systemic Lupus Erythematosus (SLE) · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 5Status Recruiting
CGTLimited DatastaleGuangdong Ruishun Biotech Co., …Phase 1

CD19-CAR-DNT cells (RJMty19, RJMty19 (CD19-CAR-DNT cells))

Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 5Status Recruiting
CGTLimited DatastaleThe Children's Hospital of Zhej…Phase 1

KN5601 (anti-CD19/BCMA CAR NK cells, anti-CD19/BCMA CAR NK cells (KN5601))

Autoimmune Diseases; Systemic Lupus Erthematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 5Status Recruiting
CGTLimited DatastaleYake Biotechnology Ltd.Phase 1

Assigned Interventions CD19/BCMA CAR T-cells (Assigned Interventions CD19/BCMA CAR T-cells)

Systemic Lupus Erythematosus; Autoimmune Diseases · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 4Status Active
CGTLimited DatastalePolina StepenskyPhase 2

HBI0101 CART (HBI0101 CART)

Multiple Myeloma, Refractory to Standard Treatment; Multiple Myeloma, Relapsed · Systemic Sclerosis (SSc)

#SystemicSclerosisSSc#CGT#Phase2#cell-gene-therapy#CAR-T+5
Trials 4Status Recruiting
CGTLimited DatastaleBeijing BiotechPhase 1

CD20/BCMA-directed CAR-T cells (CD20/BCMA-directed CAR-T cells)

Systemic Lupus Erythematosus (SLE); Immune-mediated Necrotizing Myopathy (IMNM) · CD20

#CD20#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Recruiting
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

LCAR-AIO T cells (LCAR-AIO T cells)

Multiple Sclerosis (MS); Neuromyelitis Optica Spectrum Disease (NMOSD) · Systemic Lupus Erythematosus (SLE)

#SystemicLupusErythematosusSLE#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 3Status Discontinued

1 / 3 pages

← PreviousNext →